$38.02 Billion in Sales Expected for Anthem, Inc. (NYSE:ANTM) This Quarter

Wall Street brokerages expect that Anthem, Inc. (NYSE:ANTMGet Rating) will post sales of $38.02 billion for the current quarter, according to Zacks Investment Research. Seventeen analysts have provided estimates for Anthem’s earnings, with the highest sales estimate coming in at $38.87 billion and the lowest estimate coming in at $36.83 billion. Anthem reported sales of $33.28 billion during the same quarter last year, which indicates a positive year over year growth rate of 14.2%. The business is expected to issue its next quarterly earnings results on Monday, January 1st.

According to Zacks, analysts expect that Anthem will report full year sales of $153.08 billion for the current year, with estimates ranging from $151.08 billion to $156.94 billion. For the next fiscal year, analysts anticipate that the business will report sales of $160.81 billion, with estimates ranging from $155.94 billion to $167.87 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that cover Anthem.

Anthem (NYSE:ANTMGet Rating) last announced its quarterly earnings data on Wednesday, April 20th. The company reported $8.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.81 by $0.44. The company had revenue of $38.10 billion for the quarter, compared to the consensus estimate of $37.28 billion. Anthem had a return on equity of 18.71% and a net margin of 4.33%. The firm’s revenue was up 17.6% compared to the same quarter last year. During the same period in the previous year, the business earned $7.01 EPS.

A number of brokerages have recently issued reports on ANTM. Deutsche Bank Aktiengesellschaft boosted their price objective on Anthem from $453.00 to $574.00 and gave the company a “buy” rating in a research note on Friday, April 22nd. Cowen upped their price target on Anthem from $472.00 to $642.00 in a research note on Thursday, April 21st. Argus upped their price target on Anthem from $475.00 to $500.00 and gave the stock a “buy” rating in a research note on Monday, February 7th. StockNews.com assumed coverage on Anthem in a research note on Thursday, March 31st. They set a “strong-buy” rating on the stock. Finally, SVB Leerink upped their price target on Anthem from $483.00 to $555.00 and gave the stock a “market perform” rating in a research note on Thursday, April 21st. Two research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $543.64.

Shares of NYSE:ANTM opened at $498.48 on Wednesday. The company has a market capitalization of $120.18 billion, a price-to-earnings ratio of 19.63, a P/E/G ratio of 1.41 and a beta of 0.97. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.36 and a quick ratio of 1.36. The business’s 50-day moving average is $487.92 and its 200-day moving average is $454.94. Anthem has a 1 year low of $355.43 and a 1 year high of $533.68.

The business also recently announced a quarterly dividend, which will be paid on Friday, June 24th. Shareholders of record on Friday, June 10th will be given a dividend of $1.28 per share. The ex-dividend date of this dividend is Thursday, June 9th. This represents a $5.12 annualized dividend and a dividend yield of 1.03%. This is an increase from Anthem’s previous quarterly dividend of $1.13. Anthem’s dividend payout ratio is currently 20.16%.

In related news, EVP Peter D. Haytaian sold 17,703 shares of the stock in a transaction on Thursday, March 10th. The stock was sold at an average price of $460.71, for a total value of $8,155,949.13. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Ronald W. Penczek sold 2,423 shares of the stock in a transaction on Thursday, March 3rd. The stock was sold at an average price of $463.68, for a total value of $1,123,496.64. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,889 shares of company stock worth $10,532,411. Company insiders own 0.27% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Great Diamond Partners LLC increased its stake in Anthem by 15.0% in the fourth quarter. Great Diamond Partners LLC now owns 904 shares of the company’s stock valued at $419,000 after acquiring an additional 118 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its stake in shares of Anthem by 28.1% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 65,647 shares of the company’s stock valued at $30,430,000 after buying an additional 14,406 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its stake in shares of Anthem by 7.0% during the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 27,774 shares of the company’s stock valued at $12,874,000 after buying an additional 1,814 shares during the last quarter. Sanders Capital LLC grew its stake in shares of Anthem by 9.1% during the third quarter. Sanders Capital LLC now owns 3,977,162 shares of the company’s stock valued at $1,640,909,000 after buying an additional 330,942 shares during the last quarter. Finally, Cozad Asset Management Inc. grew its stake in shares of Anthem by 27.3% during the fourth quarter. Cozad Asset Management Inc. now owns 2,724 shares of the company’s stock valued at $1,263,000 after buying an additional 585 shares during the last quarter. 84.28% of the stock is currently owned by institutional investors and hedge funds.

About Anthem (Get Rating)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Read More

Get a free copy of the Zacks research report on Anthem (ANTM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.